Health brief
Psychedelic Trauma Care and Physician Deficits
Israel launches a national psychedelic PTSD trial as hospital leaders battle worsening doctor shortages and oncology budget caps.
Health
The Health Ministry's psychedelic clinical trial moves MDMA and psilocybin into hospital settings — creating a state-sanctioned pathway for intractable PTSD.
BackgroundThe trauma burden across Israeli society reached historic levels following the October 7 atrocities and subsequent multifront warfare, overwhelming public psychiatric infrastructure. Desperate patients turned to an expanding underground black market of unregulated psychedelic practitioners.
- The trial will administer pharmaceutical-grade compounds under strict medical supervision across major psychiatric departments and general hospital facilities, standardizing psychedelic protocols nationwide.
- Controlled substances will be dispensed directly from authorized hospital pharmacies on the morning of scheduled six-to-eight-hour clinical therapy sessions, preventing diversion into unregulated street channels.
- Health Ministry officials structured the trial to establish regulated clinical protocols while curbing unsupervised underground psychedelic self-treatment among combat veterans and civilian survivors.
Health
A doubling of doctor emigration reveals that 26-hour shifts and ₪6,000 monthly starting wages are driving specialized medical talent overseas.
BackgroundIsraeli medical residents and young specialists complete lengthy specialty training while enduring 26-hour hospital shifts and baseline monthly starting salaries around ₪6,000. Foreign healthcare systems across North America actively recruit Israeli doctors with higher compensation packages and structured schedules.
- Hospital directors warned that departures are gutting intermediate leadership ranks across surgical departments and intensive care units, leaving junior interns without experienced mentors.
- Departing doctors cited excessive administrative workloads, burnout from prolonged trauma surges, and political polarization as primary departure catalysts driving them overseas.
- Medical associations urged the Finance Ministry to establish targeted retention bonuses and wage subsidies to prevent ward capacity closures across regional public hospitals.
Health
Expedited on-site licensing in London reflects Jerusalem's urgency to recruit foreign physicians before hospital shortages paralyze peripheral healthcare.
BackgroundIsrael's physician density sits at 3.5 practicing doctors per 1,000 residents, lagging well behind the OECD developed nation average of 3.9. Chronic staffing deficits are acute in peripheral medical facilities throughout the Galilee and Negev regions.
- Delegates from all four domestic health maintenance organizations and major trauma hospitals conducted on-site credential verifications and licensing exams, bypassing months of standard bureaucratic red tape.
- The recruitment push builds on immigration data showing 890 British immigrants arrived in 2025, representing a 26% increase over the previous year as professional relocations accelerated.
- Health Ministry recruiters prioritized staffing emergency departments, internal medicine wards, and regional healthcare clinics across peripheral districts where shortages are most severe.
Health
Oncologists are pressing the state health basket committee to fund breakthrough therapies — warning patients will otherwise face catastrophic out-of-pocket costs.
BackgroundIsrael's National Health Benefits Basket—the Sal Briut—is updated annually by a government-appointed committee with fixed budgetary funding to determine which new medications are fully covered by public health insurance. Treatments left out of the basket remain unaffordable for average citizens without private insurance.
- Phase 3 clinical trial findings presented at ESMO demonstrated targeted oncology regimens extended survival by up to six months in refractory lung cancers, outperforming legacy therapies.
- Novel therapies doubled survival durations for advanced gastric cancer cohorts who had exhausted standard first-line chemotherapy options, creating urgent clinical demand from treating oncologists.
- Specialists from Beilinson Hospital warned that without public basket inclusion, patients will face prohibitive monthly out-of-pocket expenses reaching tens of thousands of shekels.
Health
Health
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
